Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
Products
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Individuals with multiple sclerosis redistribute positive mechanical work from the ankle to the hip during walking.
Cerebral vasomotor reactivity in neurodegenerative diseases.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Ectopic Lymphoid Structures: Powerhouse of Autoimmunity.
Characterizing retinal structure injury in African-Americans with multiple sclerosis.
[QUALITY OF LIFE IN CARERS OF PATIENTS WITH MULTIPLE SCLEROSIS TAKING A DISEASE-MODIFYING MEDICATION: A PILOT STUDY].
Pregnancy in the Setting of Multiple Sclerosis.
Autonomic dysfunction in multiple sclerosis is better detected by heart rate variability and is not correlated with central autonomic network damage.
ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Azo polymeric micelles designed for colon-targeted dimethyl fumarate delivery for colon cancer therapy.
Conformational changes associated with L16P and T118M mutations in the membrane embedded PMP22 protein, consequential in CMT-1A.
Predictive and reactive grip force responses to rapid load increases in people with multiple sclerosis.
Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
The epidemiology of multiple sclerosis: insights to a causal cascade.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation.
Current status of biomarker research in neurology.
Pages
« first
‹ previous
…
773
774
775
776
777
778
779
780
781
…
next ›
last »